Works matching DE "VERTEPORFIN"

Results: 88

Verteporfin can Reverse the Paclitaxel Resistance Induced by YAP Over-Expression in HCT-8/T Cells without Photoactivation through Inhibiting YAP Expression.

Published in:

Cellular Physiology & Biochemistry (Karger AG), 2016, v. 39, n. 2, p. 481, doi. 10.1159/000445640

By:

Pan, Wang;
Wang, Qian;
Zhang, Yi;
Zhang, Naishu;
Qin, Jiamin;
Li, Wei;
Wang, Jing;
Wu, Fangfang;
Cao, Lingsen;
Xu, Guanglin

Publication type:

Article

In Vitro Validation of the Hippo Pathway as a Pharmacological Target for Canine Mammary Gland Tumors.

Published in:

Journal of Mammary Gland Biology & Neoplasia, 2017, v. 22, n. 3, p. 203, doi. 10.1007/s10911-017-9384-9

By:

Guillemette, Samantha;
Rico, Charlène;
Godin, Philippe;
Boerboom, Derek;
Paquet, Marilène

Publication type:

Article

Ranibizumab plus Verteporfin Photodynamic Therapy in Neovascular Age-Related Macular Degeneration: 12 Months of Retreatment and Vision Outcomes from a Randomized Study.

Published in:

Ophthalmologica, 2015, v. 233, n. 2, p. 66, doi. 10.1159/000367603

By:

Hatz, Katja;
Schneider, Ulrike;
Henrich, P. Bernhard;
Braun, Beatrice;
Sacu, Stefan;
Prünte, Christian

Publication type:

Article

Cost and Effectiveness of Therapy for Wet Age-Related Macular Degeneration in Routine Clinical Practice.

Published in:

Ophthalmologica, 2013, v. 230, n. 1, p. 34, doi. 10.1159/000350802

By:

Studnička, Jan;
Říhová, Barbora;
Rencová, Eva;
Rozsíval, Pavel;
Dubská, Zora;
Chrapek, Oldřich;
Kolář, Petr;
Kandrnal, Vít;
Demlová, Regina;
Pitrová, Šárka;
Řehák, Jiří

Publication type:

Article

Long-Term Effects of Half-Time Photodynamic Therapy on Retinal Sensitivity in Eyes with Chronic Central Serous Chorioretinopathy.

Published in:

BioMed Research International, 2020, p. 1, doi. 10.1155/2020/3190136

By:

Iwase, Takehito;
Yokouchi, Hirotaka;
Kitahashi, Masayasu;
Kubota-Taniai, Mariko;
Baba, Takayuki;
Yamamoto, Shuichi

Publication type:

Article

Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: Predisposing Factors for Visual Acuity Outcomes.

Published in:

2018

By:

Matušková, Veronika;
Vysloužilová, Daniela;
Uher, Michal

Publication type:

journal article

Prospective Comparison of Low-Fluence Photodynamic Therapy Combined with Intravitreal Bevacizumab versus Bevacizumab Monotherapy for Choroidal Neovascularization in Age-Related Macular Degeneration.

Published in:

Seminars in Ophthalmology, 2015, v. 30, n. 2, p. 112, doi. 10.3109/08820538.2013.833268

By:

Datseris, Ioannis;
Kontadakis, Georgios A.;
Diamanti, Ramza;
Datseris, Iordanis;
Pallikaris, Ioannis G.;
Theodossiadis, Panagiotis;
Tsilimbaris, Miltiadis K.

Publication type:

Article

YAP-Induced Endothelial-Mesenchymal Transition in Oral Submucous Fibrosis.

Published in:

2019

By:

Li, J.;
Yao, M.;
Zhu, X.;
Li, Q.;
He, J.;
Chen, L.;
Wang, W.;
Zhu, C.;
Shen, T.;
Cao, R.;
Fang, C.

Publication type:

journal article

Combined intravitreal ranibizumab and verteporfin photodynamic therapy versus ranibizumab alone for the treatment of age-related macular degeneration.

Published in:

Digital Journal of Ophthalmology, 2011, v. 17, p. 23, doi. 10.5693/djo.01.2011.05.003

By:

Giustolisi, Rosalia;
Fantozzi, Nicoletta;
Staltari, Mariateresa;
Marchiori, Jessica;
Mastrangelo, Olga;
Marcucci, Roberta;
Mirra, Federica;
Mazzotta, Paola;
Gabrieli, Corrado Balacco

Publication type:

Article

A combination therapy of half-dose verteporfin photodynamic therapy and intravitreal injection of ranibizumab for chronic central serous chorioretinopathy.

Published in:

Turkish Journal of Medical Sciences, 2012, v. 42, n. 4, p. 681, doi. 10.3906/sag-1101-1470

By:

TOKLU, Yasin;
ÇAKMAK, Hasan Basri;
YORGUN, Mücella ARIKAN;
ERGUN, Şule Berk;
ŞİMŞEK, Şaban

Publication type:

Article

Subfoveal koroid neovaskülarizasyonlu yaşa bağlı maküla dejenerasyonunda fotodinamik tedavi uygulaması.

Published in:

Journal of Harran University Medical Faculty / Harran Üniversitesi Tıp Fakültesi Dergisi, 2018, v. 15, n. 3, p. 194

By:

ADIBELLİ, Fatih Mehmet;
HALPERT, Michael

Publication type:

Article

Subfoveal choroidal thickness after photodynamic therapy in patients with acute idiopathic central serous chorioretinopathy.

Published in:

Therapeutics & Clinical Risk Management, 2014, v. 10, p. 37, doi. 10.2147/TCRM.S54213

By:

Yalong Dang;
Xinfeng Sun;
Yongsheng Xu;
Yalin Mu;
Manli Zhao;
Jing Zhao;
Yu Zhu;
Chun Zhang

Publication type:

Article

Efficacy of metformin and verteporfin treatment alone or in combination in a murine head and neck cancer xenograft model.

Published in:

European Journal of Oral Sciences, 2025, v. 133, n. 1, p. 1, doi. 10.1111/eos.13034

By:

Shan, Aung Phyo;
Hlaing, Khin Swe;
Leelahavanichkul, Asada;
Amornphimoltham, Panomwat

Publication type:

Article

Inhibition of YAP suppresses CML cell proliferation and enhances efficacy of imatinib in vitro and in vivo.

Published in:

Journal of Experimental & Clinical Cancer Research (17569966), 2016, v. 235, p. 1, doi. 10.1186/s13046-016-0414-z

By:

Hui Li;
Zhenglan Huang;
Miao Gao;
Ningshu Huang;
Zhenhong Luo;
Huawei Shen;
Xin Wang;
Teng Wang;
Jing Hu;
Wenli Feng

Publication type:

Article

Reduced-fluence verteporfin photodynamic therapy plus ranibizumab for choroidal neovascularization in pathologic myopia.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2017, v. 255, n. 3, p. 529, doi. 10.1007/s00417-016-3498-4

By:

Rinaldi, M.;
Semeraro, F.;
Chiosi, F.;
Russo, A.;
Romano, M.;
Savastano, M.;
dell'Omo, R.;
Costagliola, C.

Publication type:

Article

One-year outcome of combination therapy with intravitreal aflibercept and verteporfin photodynamic therapy for polypoidal choroidal vasculopathy.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2017, v. 255, n. 3, p. 541, doi. 10.1007/s00417-016-3500-1

By:

Matsumiya, Wataru;
Honda, Shigeru;
Otsuka, Keiko;
Miki, Akiko;
Nagai, Takayuki;
Imai, Hisanori;
Kusuhara, Sentaro;
Nakamura, Makoto

Publication type:

Article

The effect of photodynamic therapy on macular sensitivity in eyes with acute central serous chorioretinopathy.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2013, v. 251, n. 4, p. 1081, doi. 10.1007/s00417-012-2139-9

By:

Hagen, Stefan;
Ansari-Shahrezaei, Siamak;
Smretschnig, Eva;
Glittenberg, Carl;
Krebs, Ilse;
Graf, Alexandra;
Binder, Susanne

Publication type:

Article

Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up.

Published in:

2013

By:

Mak, Shiu;
Wong, Albert

Publication type:

Letter

Combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy.

Published in:

2013

By:

Arevalo, J.;
Espinoza, Juan

Publication type:

Letter

Intermittent Hydrostatic Pressure Promotes Cartilage Repair in an Inflammatory Environment through Hippo-YAP Signaling In Vitro and In Vivo.

Published in:

BioMed Research International, 2022, p. 1, doi. 10.1155/2022/3215461

By:

Yao, Wangxiang;
Ma, An;
Zhang, Zhen;
Zhu, Liulong

Publication type:

Article

Effects of verteporfin-mediated photodynamic therapy in breast cancer cells.

Published in:

Indian Journal of Biochemistry & Biophysics, 2020, v. 57, n. 5, p. 560

By:

Sönmez, Pınar Kılıçaslan;
Turhan, Ali;
Öztatlıcı, Mustafa;
Özbilgin, Kemal

Publication type:

Article

A rodent model of anterior ischemic optic neuropathy (AION) based on laser photoactivation of verteporfin.

Published in:

2018

By:

Min, Jing-yu;
Lv, Yanan;
Mao, Lei;
Gong, Yuan-yuan;
Gu, Qing;
Wei, Fang

Publication type:

journal article

Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy.

Published in:

2017

By:

Atik, Alp;
Yijun Hu;
Honghua Yu;
Chun Yang;
Bin Cai;
Yijing Tao;
Dongli Li;
Yan Chen;
Li Lu;
Guodong Li;
Ling Yuan;
Hu, Yijun;
Yu, Honghua;
Yang, Chun;
Cai, Bin;
Tao, Yijing;
Li, Dongli;
Chen, Yan;
Lu, Li;
Li, Guodong

Publication type:

journal article

Wet AMD market.

Published in:

Nature Reviews Drug Discovery, 2012, v. 11, n. 11, p. 827, doi. 10.1038/nrd3790

By:

Syed, Basharut A.;
Evans, James B.;
Bielory, Leonard

Publication type:

Article

A 5-year multicenter prospective cohort study on the long-term visual prognosis and predictive factors for visual outcome in Japanese patients with age-related macular degeneration: the AMD2000 study.

Published in:

Japanese Journal of Ophthalmology, 2018, v. 62, n. 2, p. 137, doi. 10.1007/s10384-017-0554-5

By:

Akagi-Kurashige, Yumiko;
Tsujikawa, Akitaka;
Yuzawa, Mitsuko;
Ishibashi, Tatsuro;
Nakanishi, Hideo;
Nakatani, Eiji;
Teramukai, Satoshi;
Fukushima, Masanori;
Yoshimura, Nagahisa;
AMD2000 study group

Publication type:

Article

Half-dose photodynamic therapy for chronic central serous chorioretinopathy evaluated by focal macular electroretinograms.

Published in:

Japanese Journal of Ophthalmology, 2017, v. 61, n. 3, p. 260, doi. 10.1007/s10384-017-0498-9

By:

Oiwa, Kazuhiro;
Kataoka, Keiko;
Maruko, Ruka;
Ueno, Shinji;
Ito, Yasuki;
Terasaki, Hiroko

Publication type:

Article

Intravitreal bevacizumab versus low-fluence photodynamic therapy for treatment of chronic central serous chorioretinopathy.

Published in:

Japanese Journal of Ophthalmology, 2012, v. 56, n. 6, p. 608, doi. 10.1007/s10384-012-0162-3

By:

Semeraro, Francesco;
Romano, Mario;
Danzi, Paola;
Morescalchi, Francesco;
Costagliola, Ciro

Publication type:

Article

Comparison of different treatment intervals between bevacizumab injection and photodynamic therapy in combined therapy for age-related macular degeneration.

Published in:

Japanese Journal of Ophthalmology, 2012, v. 56, n. 5, p. 470, doi. 10.1007/s10384-012-0154-3

By:

Sawa, Miki;
Iwata, Eiji;
Ishikawa, Kohei;
Gomi, Fumi;
Nishida, Kohji;
Terasaki, Hiroko

Publication type:

Article

Photodynamic therapy with verteporfin accelerates apoptotic bleb formation in human ameloblastoma.

Published in:

Oral Diseases, 2024, v. 30, n. 5, p. 3261, doi. 10.1111/odi.14775

By:

Yamashita, Junya;
Kimoto, Akira;
Teraoka, Shun;
Hiraoka, Yujiro;
Takeda, Daisuke;
Kakei, Yasumasa;
Shigeoka, Manabu;
Hasegawa, Takumi;
Akashi, Masaya

Publication type:

Article

The impact of interaction between verteporfin and yes-associated protein 1/transcriptional coactivator with PDZ-binding motif-TEA domain pathway on the progression of isocitrate dehydrogenase wild-type glioblastoma.

Published in:

Journal of Central Nervous System Disease, 2023, p. 1, doi. 10.1177/11795735231195760

By:

Osama, Mahmoud;
Essibayi, Muhammed Amir;
Osama, Mona;
Ibrahim, Ismail A.;
Nasr Mostafa, Mostafa;
Şakir Ekşi, Murat

Publication type:

Article

Research progress of hydroxychloroquine and autophagy inhibitors on cancer.

Published in:

2017

By:

Shi, Ting-Ting;
Yu, Xiao-Xu;
Yan, Li-Jun;
Xiao, Hong-Tao

Publication type:

journal article

Photodynamic Therapy Combined with Intravitreal Bevacizumab (Avastin) in Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration.

Published in:

Collegium Antropologicum, 2007, v. 31, n. s1, p. 71

By:

Lazić, Ratimir;
Gabrić, Nikica;
Dekaris, Iva;
Gavrić, Morena;
Bosnar, Damir

Publication type:

Article

3-year follow-up of half-dose verteporfin photodynamic therapy for central serous chorioretinopathy with OCT-angiography detected choroidal neovascularization.

Published in:

Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-92693-z

By:

Hu, Yu-Chen;
Chen, Yi-Ling;
Chen, Yen-Chih;
Chen, San-Ni

Publication type:

Article

Efficacy and safety of ranibizumab monotherapy versus ranibizumab in combination with verteporfin photodynamic therapy in patients with polypoidal choroidal vasculopathy: 12-month outcomes in the Japanese cohort of EVEREST II study.

Published in:

Clinical Ophthalmology, 2018, v. 12, p. 1789, doi. 10.2147/OPTH.S171015

By:

Takahashi, Kanji;
Ohji, Masahito;
Terasaki, Hiroko;
Honda, Shigeru;
Margaron, Philippe;
Guerin, Tadhg;
Yuzawa, Mitsuko

Publication type:

Article

Long-term outcomes in half-dose verteporfin photodynamic therapy for chronic central serous retinopathy.

Published in:

Clinical Ophthalmology, 2017, v. 11, p. 2145, doi. 10.2147/OPTH.S151933

By:

Dhirani, Nadeem Ali;
Yelin Yang;
Somani, Sohel

Publication type:

Article

Combination verteporfin photodynamic therapy ranibizumab-dexamethasone in choroidal neovascularization due to age-related macular degeneration: results of a phase II randomized trial.

Published in:

Clinical Ophthalmology, 2017, v. 11, p. 223, doi. 10.2147/OPTH.S119510

By:

Gallemore, Ron P.;
Wallsh, Josh;
Hudson, Henry L.;
Ho, Allen C.;
Chace, Richard;
Pearlman, Joel

Publication type:

Article

Ranibizumab in monotherapy and combined with photodynamic therapy for retinal angiomatous proliferation.

Published in:

Clinical Ophthalmology, 2016, v. 10, p. 861, doi. 10.2147/OPTH.S106092

By:

Arias, Luis;
Gómez-Ulla, Francisco;
Ruiz-Moreno, José M.

Publication type:

Article

Current and emerging treatment options for myopic choroidal neovascularization.

Published in:

Clinical Ophthalmology, 2015, v. 9, p. 733, doi. 10.2147/OPTH.S49437

By:

El Matri, Leila;
Chebil, Ahmed;
Kort, Fedra

Publication type:

Article

Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy.

Published in:

Clinical Ophthalmology, 2014, v. 8, p. 685, doi. 10.2147/OPTH.S58617

By:

Alkin, Zeynep;
Perente, Irfan;
Ozkaya, Abdullah;
Alp, Dilek;
Agca, Alper;
Demet Aygit, Ebru;
Korkmaz, Selcuk;
Taylan Yazici, Ahmet;
Demirok, Ahmet

Publication type:

Article

A case of presumed choroidal metastasis from carcinoid tumor treated by photodynamic therapy with verteporfin.

Published in:

2013

By:

Setsuko Kawakami;
Yoshihiro Wakabayashi;
Hiroshi Goto

Publication type:

Case Study

Profile of verteporfin and its potential for the treatment of central serous chorioretinopathy.

Published in:

Clinical Ophthalmology, 2013, v. 7, p. 1867, doi. 10.2147/OPTH.S32177

By:

Karim, Shaheen P.;
Adelman, Ron A.

Publication type:

Article

Five-year results of photodynamic therapy with verteporin for Japanese patients with neovascular age-related macular degeneration.

Published in:

Clinical Ophthalmology, 2013, v. 7, p. 615, doi. 10.2147/OPTH.S43566

By:

Tsuchihashi, Takashi;
Mori, Keisuke;
Ueyama, Kazuhiro;
Yoneya, Shin

Publication type:

Article

Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy.

Published in:

Clinical Ophthalmology, 2013, v. 7, p. 87, doi. 10.2147/OPTH.S39584

By:

Ratanasukon, Mansing;
Thongthong, Koblarp;
Bhurayanontachai, Patama;
Jirarattanasopa, Pichai

Publication type:

Article

Rabbit model of ocular indirect photodynamic therapy using a retinoblastoma xenograft.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2017, v. 255, n. 12, p. 2363, doi. 10.1007/s00417-017-3805-8

By:

Kim, Jonathan;
Jacobsen, Bradley;
Zolfaghari, Emily;
Ferrario, Angela;
Chevez-Barrios, Patricia;
Berry, Jesse;
Lee, Diana;
Rico, Grecia;
Madi, Ingy;
Rao, Narsing;
Stachelek, Kevin;
Wang, Lei-chi;
Gomer, Charles

Publication type:

Article

Clinical research on one-third dose verteporfin photodynamic therapy in the treatment of chronic central serous chorioretinopathy.

Published in:

European Review for Medical & Pharmacological Sciences, 2018, v. 22, n. 2, p. 278

By:

HUA, L.;
LIN, B.;
HONG, J.;
MIN, H.-B.;
HAN, W.-L.;
ZHOU, T.-Y.;
ZHANG, Z.-Q.

Publication type:

Article

Anti-Cancer Activity of Verteporfin in Cholangiocarcinoma.

Published in:

Cancers, 2023, v. 15, n. 9, p. 2454, doi. 10.3390/cancers15092454

By:

Golino, Jihye L.;
Wang, Xin;
Bian, Jing;
Ruf, Benjamin;
Kelly, Michael;
Karim, Baktiar O.;
Cam, Maggie C.;
Xie, Changqing

Publication type:

Article

A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with Verteporfin.

Published in:

Cancers, 2023, v. 15, n. 4, p. 1085, doi. 10.3390/cancers15041085

By:

Liang, Jiyong;
Fang, Dexing;
Gumin, Joy;
Najem, Hinda;
Sooreshjani, Moloud;
Song, Renduo;
Sabbagh, Aria;
Kong, Ling-Yuan;
Duffy, Joseph;
Balyasnikova, Irina V.;
Pollack, Seth M.;
Puduvalli, Vinay K.;
Heimberger, Amy B.

Publication type:

Article

Hippo in Gastric Cancer: From Signalling to Therapy.

Published in:

Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092282

By:

Seeneevassen, Lornella;
Dubus, Pierre;
Gronnier, Caroline;
Varon, Christine

Publication type:

Article

Constitutive Activation of p62/Sequestosome-1-Mediated Proteaphagy Regulates Proteolysis and Impairs Cell Death in Bortezomib-Resistant Mantle Cell Lymphoma.

Published in:

Cancers, 2022, v. 14, n. 4, p. 923, doi. 10.3390/cancers14040923

By:

Quinet, Grégoire;
Xolalpa, Wendy;
Reyes-Garau, Diana;
Profitós-Pelejà, Núria;
Azkargorta, Mikel;
Ceccato, Laurie;
Gonzalez-Santamarta, Maria;
Marsal, Maria;
Andilla, Jordi;
Aillet, Fabienne;
Bosch, Francesc;
Elortza, Felix;
Loza-Alvarez, Pablo;
Sola, Brigitte;
Coux, Olivier;
Matthiesen, Rune;
Roué, Gaël;
Rodriguez, Manuel S.

Publication type:

Article

YAP1 Is a Potential Predictive Molecular Biomarker for Response to SMO Inhibitor in Medulloblastoma Cells.

Published in:

Cancers, 2021, v. 13, n. 24, p. 6249, doi. 10.3390/cancers13246249

By:

Alencastro Veiga Cruzeiro, Gustavo;
de Almeida Magalhães, Taciani;
Ribeiro de Sousa, Graziella;
Bonfim Silva, Ricardo;
Alberto Oliveira de Biagi Junior, Carlos;
Ferreira das Chagas, Pablo;
Gomes de Paula Queiroz, Rosane;
Alberto Scrideli, Carlos;
Gonzaga Tone, Luiz;
Terci Valera, Elvis

Publication type:

Article